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ORIGINAL ARTICLE
Diffusion-Weighted Imaging and
Diagnosis of Transient Ischemic Attack
Miriam Brazzelli, PhD,1,2 Francesca M. Chappell, PhD,1,3 Hector Miranda, MD,1,4
Kirsten Shuler, BSc,1,3 Martin Dennis, MD,1 Peter A. G. Sandercock, MD,1,3
Keith Muir, MD,3,5 and Joanna M. Wardlaw, MD1,3
Objective: Magnetic resonance (MR) diffusion-weighted imaging (DWI) is sensitive to small acute ischemic lesions
and might help diagnose transient ischemic attack (TIA). Reclassification of patients with TIA and a DWI lesion as
“stroke” is under consideration. We assessed DWI positivity in TIA and implications for reclassification as stroke.
Methods: We searched multiple sources, without language restriction, from January 1995 to July 2012. We used
PRISMA guidelines, and included studies that provided data on patients presenting with suspected TIA who under-
went MR DWI and reported the proportion with an acute DWI lesion. We performed univariate random effects meta-
analysis to determine DWI positive rates and influencing factors.
Results: We included 47 papers and 9,078 patients (range5 18–1,693). Diagnosis was by a stroke specialist in 26 of
47 studies (55%); all studies excluded TIA mimics. The pooled proportion of TIA patients with an acute DWI lesion
was 34.3% (95% confidence interval [CI]530.5–38.4, range59–67%; I25 89.3%). Larger studies (n> 200) had lower
DWI-positive rates (29%; 95% CI523.2–34.6) than smaller (n< 50) studies (40.1%; 95% CI533.5–46.6%; p5 0.035),
but no other testable factors, including clinician speciality and time to scanning, reduced or explained the 7-fold
DWI-positive variation.
Interpretation: The commonest DWI finding in patients with definite TIA is a negative scan. Available data do not
explain why 2=3 of patients with definite specialist-confirmed TIA have negative DWI findings. Until these factors are
better understood, reclassifying DWI-positive TIAs as strokes is likely to increase variance in estimates of global
stroke and TIA burden of disease.
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Stroke is the third commonest cause of death world-wide and the commonest cause of dependency in
adults.1 There are nearly 6 million deaths, 15 million
strokes, and 7.5 million transient ischemic attacks (TIAs)
worldwide per year. Patients with TIA are at high risk of
early recurrent stroke.2 Rapid diagnosis and prompt
treatment of underlying risk factors are essential to pre-
vent stroke and reduce its global disease burden.
The diagnosis of TIA is mainly based on the clini-
cal history, because neurological signs usually disappear
quickly.3 Forty-five percent of referrals to TIA clinics are
nonvascular mimics,4,5 but the observer agreement for
diagnosis of TIA versus mimic is imperfect.6 For all these
reasons, a confirmatory test for TIA would be helpful.
Magnetic resonance (MR) with diffusion-weighted
imaging (DWI) is very sensitive to small ischemic
lesions,7 and TIA patients with an acute ischemic lesion
on DWI are at increased risk of recurrent stroke.8–10
Thus, DWI could both improve diagnosis of TIA and
predict short-term stroke risk. National stroke guidelines
now recommend use of DWI in TIA patients.11,12 Addi-
tionally, a change from a time-based to a tissue-based
definition of TIA/stroke using DWI has been proposed13
and is now under consideration by the World Health
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Organization (http://apps.who.int/classifications/icd11/
browse/f/en) and recommended by the American Stroke
Association.14
Stroke is both common and associated with a huge
global disease burden; thus, identification should be
based on the most robust epidemiological data. In previ-
ous reviews (2,457 patients, 26 studies), DWI showed an
acute ischemic lesion in 13 to 67% of patients (mean-
5 37%, standard deviation5612%), but the apparently
low rate of positive scans and reasons for the large var-
iance were not explored.15,16 We analyzed all available
literature to obtain the best estimate of the proportion of
TIA patients with an acute ischemic lesion on DWI, and
to determine what factors influence that proportion, so
as to inform use of DWI in TIA/stroke diagnosis.
Patients and Methods
We used the PRISMA guidelines for systematic reviews of
observational studies.17 We aimed to identify all published
studies in which TIA patients were assessed by DWI irrespective
of aims, study design, or clinical setting. A detailed study proto-
col is available upon request.
Study Identification
We searched MEDLINE (Ovid, New York, NY) from January
1995 to July 2012, covering the time period from the introduc-
tion of DWI to clinical practice. We did not apply any lan-
guage restrictions. The MEDLINE search strategy included
both subject headings (MeSH terms) and text words for the tar-
get condition (eg, stroke, TIA, minor stroke) and the imaging
modality under investigation (magnetic resonance imaging
[MRI], DWI). We searched EMBASE, translating the MED-
LINE MeSH terms into the corresponding terms available in
the Emtree vocabulary. The searches were initially run in
November 2010 and updated in July 2012 (details see online
supplement). We also hand-searched proceedings of the Interna-
tional and European Stroke Conferences (2011, 2012), con-
tacted experts in the field, and searched reference lists and the
most recent issues of Stroke, Cerebrovascular Diseases, and Euro-
pean Neurology (not yet indexed in MEDLINE or EMBASE) to
identify further relevant studies.
Inclusion/Exclusion Criteria
One review author examined the titles and abstracts and retrieved
all potentially relevant citations in full. A second reviewer double-
checked the search results. Doubtful papers were discussed with a
third reviewer. We retained full-text articles that focused on pri-
mary studies of suspected TIA patients investigated with MR
DWI. We excluded studies that did not assess patients with
DWI, studies that did not report the proportion of patients with
positive DWI lesions, and duplicate data.
Data Extraction
Two review authors independently extracted data; disagreements
were resolved by discussion or referred to a third author. We
recorded data on study methods (eg, setting, study design),
characteristics of patients (TIA vs minor stroke), and imaging
findings (DWI-positive brain lesions) as the proportion of
patients with a recent ischemic lesion on DWI. We also col-
lected information on study design: quality, including blinding,
prospective versus retrospective, consecutive or not, definition
of TIA (time or tissue based), timing of the imaging assess-
ment, field strength, who read the imaging, definition of posi-
tive DWI, specialty of the evaluating clinicians, inclusion of
TIA alone or also minor stroke, and study setting (specialist
neurology clinic, emergency department, other). To assess study
quality, we followed best practice18 by identifying methodologi-
cal characteristics that were most likely to explain any heteroge-
neity (listed in Supplementary Tables 1 and 2).
Data Synthesis
We calculated the pooled proportion of TIA patients with a
positive DWI lesion using univariate random effects meta-
analysis performed in R 2.8.0, with within-study variance mod-
eled as binomial (DiagMeta package for analysis) because out-
comes were proportions. Confidence intervals (CIs) were 95%.
Heterogeneity between studies was assessed with I2 statistics,19
using the statistical software R 2.14.2 (cran.r-project.org). We
assessed potential sources of heterogeneity using SAS 9.3
PROC NLMIXED (www.sas.com) including: specialist versus
nonspecialist units, evaluation by neurologist/stroke physician
versus other specialties, retrospective versus prospective studies,
study size, time from TIA to imaging, and inclusion of patients
with minor stroke as well as TIA. Study size was categorized
(necessary due to difficulties with model fit when using individ-
ual study sizes) into small (<50 patients), medium (50–99),
large (100–199), and very large (>200).
Results
Number of Studies
The electronic searches identified 7,983 citations (Sup-
plementary Fig 1); 185 potentially relevant studies under-
went detailed assessment of the full-text articles. Hand-
searching identified 4 more includable papers. We
excluded 127 reports, mostly because they did not pro-
vide the number of patients with positive DWI lesions.
Forty-five full-text studies (published in 58 reports) and
2 abstracts met the inclusion criteria, for a total of 47
studies.
Critical Appraisal
The 47 studies included 18 prospective and 17 retrospec-
tive cohort studies (12 did not state their design; see
Supplementary Table 1). Twenty-six studies recruited
consecutive patients, but the rest were not consecutive or
did not give the information. All studies used a time-
based definition of TIA, except 2 that did not give a def-
inition; none used a tissue-based definition. Two studies
assessed population-based cohorts, 7 assessed hospital-
based cohorts, 8 assessed patients from emergency
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departments, 27 assessed cohorts from specialist stroke or
neurology units, and 3 did not specify the source. The
TIA was diagnosed by a neurologist or stroke specialist
in a total of 27 of 47 (57%) studies; the remaining 20
did not report who made the diagnosis but were auth-
ored by stroke specialists. Virtually all imaging was per-
formed on 1.5T scanners. In 21 studies a
neuroradiologist was involved in scan reading, but most
studies did not state who read the images, or the criteria
used for determining when DWI was positive (see Sup-
plementary Table 2). Timing of DWI assessment after
symptom onset varied (see Supplementary Table 1); 18
studies assessed patients within 24 hours, 6 within 48
hours, 12 within 7 days, 3 within 2 weeks, and 2 within
3 weeks of symptom onset; 6 did not provide this infor-
mation. Thirty-nine studies only included TIA patients,
and 820–27 included some patients with minor stroke as
well as TIA, but only 424–27 reported the results for
minor stroke separately from TIA.
Main Findings
The 47 studies included 9,078 (median5 91, interquartile
range5 42–161, range5 18–1,693) TIA patients; 16
studies (34%) included <50 patients (Supplementary Fig
2). An acute DWI lesion was present in 3,048 of 9,078
patients (pooled proportion with a positive
DWI5 34.3%, 95% CI5 30.5–38.4%; Fig 1), with sub-
stantial between-study heterogeneity (I25 89.3%). The
frequency of positive DWI findings varied from 9 to 67%
(ie, 7-fold) between studies (see Supplementary Table 1).
Sources of Heterogeneity
Studies varied in several respects (see Supplementary
Tables 1 and 2). We explored reasons for heterogeneity
FIGURE 1: Proportion of patients with transient ischemic attack and visible ischemic lesion on diffusion-weighted imaging.
Note that Ay et al 2009 includes 2 earlier studies by Ay et al; see Supplementary Table 1. CI5 confidence interval.
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using comparisons with adequate data and that were the
most clinically relevant: study size, year of publication,
inclusion of minor stroke and TIA versus just TIA, time
to scanning, retrospective versus prospective studies,
study setting, and specialty of the evaluating clinician.
Only study size influenced heterogeneity; the DWI-
positive proportion decreased significantly as study size
increased (Fig 2) from 40.1% (95% CI5 33.5–46.6) in
studies of <50 patients to 28.9% (95% CI5 23.2–34.6)
in studies of >200 patients, a 4% (95% CI5 0.3–8;
p5 0.035) significant reduction in the DWI-positive
proportion per size category. Studies published up to
2007 had similar heterogeneity (I25 78.8%) to those
published from 2007 onward (I25 92.5%), but note
FIGURE 2: Comparison of study size and proportions with a positive lesion on diffusion-weighted imaging (DWI). Small, £50;
medium, 50 to 99; large, 100 to 200; very large, 200. The numbers in the right hand column are the number of patients with
a DWI1ve TIA / total patients in that study.
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that earlier studies were smaller, thus confounding this
comparison (Supplementary Fig 3).
Four studies provided data separately for patients with
TIA and minor stroke24–27; the proportion of patients with
minor stroke and a DWI ischemic lesion was 47%,25
70%,26 and 100%.24,27 The 2 studies in which all minor
stroke patients showed a positive DWI lesion were very
small, and 1 focused on patients with high-grade sympto-
matic carotid stenosis.24 Four other studies included
patients with minor stroke and TIA but did not report the
results separately20–23; the proportion of patients with visi-
ble ischemic lesions on DWI (53%,23 28%,20 39%,21
39%22) overlapped with the 47 to 100% in patients with
minor stroke listed above and was not noticeably higher
than in the studies reporting on TIA alone.
There was no obvious effect of increasing time from
symptom onset on the DWI-positive proportion using the
available aggregate data (Fig 3, details in Supplementary
Table 2). Most studies scanned patients within 8 days,
when the proportion with a DWI lesion ranged from 9 to
68%. There was also no readily apparent difference
between studies that reported average times and those that
reported maximum times to imaging. Among individual
studies’ analyses, 11 reported no association between DWI
positivity and time, 11 reported an association, and 25 did
not report whether there was an association. Further
attempts to investigate the relationship between the pro-
portion that were DWI positive and time to imaging failed
to meet statistical modeling assumptions.
The other potential sources did not explain hetero-
geneity. The DWI-positive rate was just as varied among
the prospective as in the retrospective studies (differ-
ence5 1%, 95% CI5 0.0–11%; p5 0.84; I25 94.1%
and 85.5%, respectively; Fig 4), among the 27 studies
where all patients were examined and diagnosed by a
neurologist/stroke physician as in the 20 studies where
the examination was not by a stroke specialist or the spe-
cialty was not stated (difference5 6%, 95% CI5 0.0–
14; p5 0.15; I2 92.6% and 78.1%, respectively; Fig 5),
and in specialist units versus all other settings (differ-
ence5 4%, 95% CI5 0–12%; p5 0.29; I2 90.6% and
87.5%, respectively; Supplementary Fig 4). It was not
possible to examine population versus nonpopulation
studies, as there were only 2 of the former. Most studies
did not provide information on DWI-positive TIA rates
by individual patient characteristics, thus precluding fur-
ther assessment or meta-analysis of patient characteristics
that influence DWI-positive rates.
Discussion
The 9,078 patients in 47 studies show that on average
only 34.3% of patients had a DWI lesion; thus, the
commonest DWI finding in TIA is a negative scan. The
largely unexplained 7-fold variation in positivity suggests
that DWI does not provide a consistent or predictable
basis for defining stroke. Adding a highly variable test
(DWI) to clinical TIA diagnosis (also variable) is likely
to increase rather than reduce variability of TIA/stroke
diagnosis, as it is mathematically impossible for both sen-
sitivity and specificity to increase if the results of 2 tests
are merged, whether they are combined using “and” or
“or”;28 instead, sensitivity or specificity will decrease,
thus increasing diagnostic variability.
Only study size explained heterogeneity, large stud-
ies (n 200 patients) having 25% fewer DWI-positive
patients (29%) than small studies (n 50, 40%), point-
ing to an undue influence of study methods on DWI-
positive rates (see Fig 2).29 Two papers published since
the end of our search describe DWI-positive rates in a
population-based study involving the same 15 hospi-
tals.30,31 One reported on 1,862 patients recruited over
36 months from November 2007, of whom 11% were
DWI positive;30 the other extended the sample to 3,724
patients recruited over 54 months from November 2007,
of whom 32.2% were DWI positive.31 No reason was
given for this 3-fold difference, the recruitment methods,
definitions, and assessments being identical in all other
respects. These DWI-positive rates are very consistent
with our meta-analysis and confirm the variability of
DWI in TIA by demonstrating that a 3-fold difference
in DWI-positive rate can be made to occur within 1
region simply by changing the recruitment period. If the
DWI-positive TIAs were classified as strokes, then a sub-
stantial fluctuation in stroke would have been recorded
in this region.
FIGURE 3: Scatter plot of time to imaging versus proportion
of patients with a positive diffusion-weighted imaging (DWI)
scan. Average time may indicate either a mean or median
time.
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We found no evidence that the DWI-positive rate
varied with time between TIA and scanning (see Fig 3),
either on summary analysis of several time parameters or
in individual studies’ reports (see Supplementary Table
2). DWI lesions may disappear very rapidly, for example,
being present at 4 hours after symptom onset but resolv-
ing completely from DWI and other MR sequences by
24 hours, or not being visible on hyperacute imaging but
becoming visible at 24 to 48 hours,32 indicating some
instability of DWI. Eleven studies reported no associa-
tion between symptom duration and DWI positivity, and
11 other studies reported a positive association; this
FIGURE 4: Comparison of prospective versus retrospective studies. DWI5diffusion-weighted imaging. The numbers in the
right hand column are the number of patients with a DWI1ve TIA / total patients in that study.
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50:50 split suggests that symptom duration is a less con-
sistent factor than might be expected. The 7-fold varia-
tion in DWI-positive rate was not explained by
prospective or retrospective study design (see Fig 4), spe-
cialist versus nonspecialist doctors/services (Fig 5), inclu-
sion of minor stroke and TIA versus TIA alone, older
versus recent publication (heterogeneity was worse in
recent publications; see Supplementary Fig 3), study set-
ting (see Supplementary Fig 4), or inclusion of mimics
(mimics were excluded).
The work has strengths. We included 33 more
patients (9,000 vs 2,500) and 80% more studies than
previous reviews,16,33 including 35 studies published
within their time period. We used rigorous methods and
multiple overlapping searches; several authors double-
checked the data. We assessed the most clinically relevant
FIGURE 5: Comparison of evaluating physician’s specialty and proportion with positive lesion on diffusion-weighted imaging
(DWI). The numbers in the right hand column are the number of patients with a DWI+ve TIA / total patients in that study.
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sources of heterogeneity for which there were data (hav-
ing 47 studies allows 4 factors to be examined reliably;
http://handbook.cochrane.org/chapter_9/9_6_5_1_ensur-
e_that_there_are_adequate_studies_to_justify.htm). There
are also weaknesses. Analysis of original data in an indi-
vidual patient data meta-analysis might be more informa-
tive but would be limited by the primary data quality.
We were not able to assess the impact of the proportion
of TIA patients in each study who did not have DWI, as
this information was largely missing; most studies
reported only on patients who did have DWI and the
findings. Not all patients can have MRI anyway, due to
claustrophobia or contraindications. If variation in the
proportion scanned were a major source of variation in
DWI positive rate, then we might have seen more differ-
ence between retrospective and prospective, or between
expert-assessed and non–expert-assessed patients, but this
was not the case. We did not perform complete duplicate
assessments but used multiple cross checks between
reviewers to ensure validity. That we found more data in
the time frame than 2 previous reviews suggests that our
methods were sensitive. We provide study quality
markers in Supplementary Tables 1 and 2; these were
used to assess heterogeneity, there being no valid tool for
assessment of nonrandomized studies.18
What are the implications? There were no data for
calculating sensitivity or specificity of DWI in TIA/
minor stroke, all patients with mimics or hemorrhage
being excluded, although TIA mimics make up about
45% of clinic referrals, and occasional small intracerebral
hemorrhages can present with TIA. The proportion of
TIA patients without a visible ischemic lesion on DWI
(65.7%) would be even higher if the denominator were
all patients attending the clinic including the mimics
rather than only those with a definite TIA. Assuming
that the 45% of patients attending stroke prevention
clinics with a final diagnosis of mimic did not have a
DWI-visible lesion (which would be incorrect, as some
with migraine, postictal states, hypoglycemia,34 multiple
sclerosis, etc might have DWI-positive lesions) would
result in much larger proportions of DWI-negative scans.
As an approximation, DWI would be positive in 19% of
unselected patients referred with suspected TIA, leaving a
large proportion (81%) of negative, noncontributory
scans.
DWI may be useful to identify patients at increased
risk of recurrent stroke, although it does not reliably
identify patients with established risk factors for recurrent
stroke, for example, atrial fibrillation or carotid stenosis,
and although DWI-negative TIAs might be at lower risk
of recurrent stroke, they still have some risk.31,35 There-
fore, DWI-negative patients still require carotid and car-
diac investigations and should be offered effective risk-
factor modification.
The use of MR in stroke is rising rapidly, increasing
by 235% in 10 states in the USA from 28% of strokes in
1999 to 66% in 2008.36 The cost of diagnostic imaging
rose by 213% between 1999 and 2007 in the USA,36 mak-
ing it the single fastest growing component of hospital
costs. Despite this, a recent study found no data to justify
the increased use of MR.37 A statistically significant associ-
ation between a new marker and cerebrovascular risk is not
enough to conclude that its use in clinical practice will
improve clinical outcomes.38 The impact of diagnostic
strategies, particularly costly ones, should be tested on clin-
ically important outcomes38 prior to changing practice.
There is wide geographical variation in use of MR
in stroke, from 55% of stroke patients in Oregon to
79% in Arizona.36 A change in the definition of TIA/
stroke14 would result in more TIAs being converted to
strokes in high MR user states like Arizona than in low
MR user states like Oregon. This would decrease the
severity of “stroke” and appear to improve stroke out-
comes in Arizona by diluting the clinically based strokes
with these DWI-positive TIAs, compared with regions
with less MR usage like Oregon.39 The prognosis of TIA
would improve where MRI rates were high, because
DWI-positive TIAs (known to have a higher rate of
recurrent stroke) would be reclassified as stroke, leaving
the DWI-negative TIAs (with a better prognosis) classi-
fied as TIAs. Even with high availability of MR, a delay
in access for 1 patient group, for example, the elderly or
women,40 would result in more TIA patients having neg-
ative DWI and fewer being reclassified as stroke, so the
severity of stroke and stroke outcomes would appear
worse in these low MR access groups. The effect would
be even greater in high versus low income countries, ren-
dering cross-sectional surveys of global disease burden1 or
risk factors, and longitudinal studies of trends in global
disease burden, highly unpredictable and difficult to
interpret. In many patients (about 1=3), the DWI-positive
lesion if present soon after the TIA does not convert to a
visible lesion on other sequences when scanning is
repeated later (ie, a tissue diagnosis of stroke would
become a diagnosis of TIA).41 The totality of the data
on DWI in TIA suggest that it will be important to
retain an awareness of the variability of DWI positivity
in patients with TIA (and that we lack a clear under-
standing of what drives that variability) in countries or
hospitals were the time-based definition is replaced by a
tissue-based definition, at least until the heterogeneity is
better understood, and MR with DWI is universally and
immediately accessible for all patients with suspected
TIA or stroke.
ANNALS of Neurology
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